Two recent studies have brought new hope in the fight against HIV. These studies, published in the journal Nature, show promising results for long-term treatments. The research involved over 40 experts from around the world, including scientists from Seattle. The first study focused on a new treatm
The immune system's response to HIV treatment can vary greatly among individuals. Some men who have sex with men (MSM) living with HIV do not experience a full immune recovery, even with antiretroviral therapy (ART). This is a critical issue because it highlights the complexity of HIV treatment and
In a surprising turn of events, a significant HIV research project targeting Black and Hispanic gay men has been given a second chance after a court ruling. However, the scientific community remains on edge due to ongoing political interference. The National Institutes of Health (NIH) initially can
A major breakthrough in HIV prevention has just been approved by the FDA. The drug, called Yeztugo, is based on research done by a biochemist from the University of Utah. This drug is special because it can protect people from HIV for a long time, up to six months. It works by stopping the virus fro
The fight against HIV just got a new ally. It is the same technology that made COVID-19 vaccines possible. mRNA, or messenger RNA, is a set of instructions for genes. It is not a new discovery. It has been around for a while. It is only now that it is being used in new ways. Scientists in Austr
In many developing nations, there's a significant problem. Young people, aged 10 to 24, are often not included in HIV research. This is a big deal because it makes it tough to figure out how to help them. These young adults and adolescents are often left in the dark when it comes to understanding an
The Department of Government Efficiency task force recently announced a massive cut of $109 million in federal grants to UCLA. This decision has far-reaching consequences, especially for HIV research and patient care. One of the most affected areas is a study that had enrolled over 200 HIV-positive
When it comes to making decisions about sharing individual genetic research results, people living with HIV have strong opinions. A study in Uganda asked 221 people receiving HIV care what role they wanted in deciding how to get information from genetic research. Most participants (122, 55. 2%) want
The world of medicine is always on the hunt for new ways to help the human body. There is an interesting case of scientists working with what can be described as a vaccine. This unique vaccine is made from what they call a "HIV envelope glycoprotein (Env) immunogens. " by stabilising it which is
